98%
921
2 minutes
20
Background: Stereotactic radiotherapy (SRT) is the main treatment for patients with 1 to 3-5 brain metastases (BMs) but with the compromise of a higher risk of distant brain failure (DBF) in comparison with whole brain radiotherapy. Early DBF has a significant negative impact on overall survival (OS). We propose to build and validate a prediction model of early DBF.
Methods: Early DBF was defined as the appearance of unknown BMs on the first post-SRT magnetic resonance imaging (MRI). A nomogram was built for the prediction of early DBF using patients from a cohort of 537 SRT courses. The nomogram was evaluated for early DBF classification using the chi-squared test. Prediction of DBF-free survival and OS was tested using Kaplan-Meier curves and the log-rank test. The model was validated on an external cohort of 160 subsequently delivered SRT courses.
Results: In the cohort of 537 SRT courses, early DBF occurred in 17% cases. The number of BMs and the DS-GPA score were significant predictors of early DBF. The nomogram demonstrated robust performances for early DBF classification (χ 23.7, < .0001), DBF-free survival (χ 35.5 < .0001, Figure 1), and OS (χ 38.9, < .0001). On the validation cohort, the same nomogram achieved a χ of 15.3, = .0005 for DBF-free survival and a χ of 8.6, = .01 for OS.
Conclusion: Our study provides a robust predictive model for early DBF, validated in an independent cohort. This nomogram could improve clinical outcomes and treatment personalization.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12311934 | PMC |
http://dx.doi.org/10.1093/noajnl/vdaf151 | DOI Listing |
Neurooncol Adv
July 2025
INSERM, LaTIM UMR 1101, University of Western Brittany, Brest, France.
Background: Stereotactic radiotherapy (SRT) is the main treatment for patients with 1 to 3-5 brain metastases (BMs) but with the compromise of a higher risk of distant brain failure (DBF) in comparison with whole brain radiotherapy. Early DBF has a significant negative impact on overall survival (OS). We propose to build and validate a prediction model of early DBF.
View Article and Find Full Text PDFBackground: Group B (GBS) is a leading infectious cause of neonatal morbidity and mortality worldwide, yet data on longer-term outcomes in children remain limited. We aimed to assess the risk of neurodevelopmental impairments (NDIs) in GBS survivors and to explore effect modification by sex and prematurity.
Methods: We performed a population-based cohort study of liveborn infants in Ontario between April 2012 and March 2018, using linked birth registry, laboratory, and health administrative databases.
J Gerontol B Psychol Sci Soc Sci
May 2025
Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Institut de Neurociències, Universitat de Barcelona, and Institut de Recerca Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Objectives: Bilingualism can stimulate brain plasticity and is often associated with better executive function. We investigated whether language usage was related to the volume of white matter lesions in a cohort of middle-aged to older adults with different multilingual characteristics, including monolingualism in daily life (use of one language), bilingualism (use of two languages), and multilingualism (active use of 3 languages, i.e.
View Article and Find Full Text PDFCell Host Microbe
April 2025
School of Biological Sciences, University of California, San Diego, La Jolla, San Diego, CA 92093, USA. Electronic address:
Many eukaryotic viruses require membrane-bound compartments for replication, but no such organelles are known to be formed by prokaryotic viruses. Bacteriophages of the Chimalliviridae family sequester their genomes within a phage-generated organelle, the phage nucleus, which is enclosed by a lattice of the viral protein ChmA. We show that inhibiting phage nucleus formation arrests infections at an early stage in which the injected phage genome is enclosed within a membrane-bound early phage infection (EPI) vesicle.
View Article and Find Full Text PDFBMJ Med
September 2024
Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.